SAMRAT PHARMACHEM LTD.-$
BSE: 530125
Revenue & Profit Trend
in croresMargin Trend
percentage| Period | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|---|---|---|
| INCOME | |||||||
| Revenue | 71.77+13.2% | 63.43-19.6% | 78.87+4.3% | 75.65+6.2% | 71.20+11.8% | 63.66-9.3% | 70.17 |
| Other Income | -0.31-176.5% | 0.40+733.7% | 0.05-93.0% | 0.69+744.3% | -0.11-2782.5% | 0.00-99.2% | 0.49 |
| Total Income | 71.47+12.0% | 63.83-19.1% | 78.92+3.4% | 76.34+7.4% | 71.10+11.7% | 63.66-9.9% | 70.66 |
| EXPENSES | |||||||
| Expenditure | 73.34+13.9% | 64.39-19.2% | 79.67+4.6% | 76.14+6.5% | 71.46+19.6% | 59.75-11.0% | 67.14 |
| Tax | 0.16+251.5% | -0.11+33.2% | -0.16-136.9% | 0.44+1123.2% | 0.04-96.8% | 1.13+31.6% | 0.86 |
| PROFIT | |||||||
| PBT | -1.87-230.3% | -0.57+24.2% | -0.75-460.2% | 0.21+157.2% | -0.36-109.3% | 3.91+11.2% | 3.52 |
| Net Profit | -2.04-343.2% | -0.46+21.8% | -0.59-156.6% | -0.23+42.7% | -0.40-114.3% | 2.79+4.7% | 2.66 |
| KEY METRICS | |||||||
| OPM % | -1.73%-0.69pp | -1.04%-0.58pp | -0.46%-0.62pp | 0.16%-0.02pp | 0.18%-5.55pp | 5.73%+1.89pp | 3.84% |
| NPM % | -2.85%-2.13pp | -0.72%+0.02pp | -0.74%-0.44pp | -0.30%+0.26pp | -0.56%-4.93pp | 4.37%+0.60pp | 3.77% |
| EPS | 6.59+342.3% | 1.49-21.6% | 1.90+156.8% | 0.74-42.6% | 1.29-85.7% | 9.01+4.6% | 8.61 |
Corporate Events
Board Meeting
The Board of Directors meeting is scheduled to consider and …
BSE Filing ↗Board Meeting
To consider, approve, and take on record the Audited Standal…
BSE Filing ↗Board Meeting
consider and approve the un-audited financial results under …
BSE Filing ↗Board Meeting
Consider and approve the Un-audited financial results
BSE Filing ↗Board Meeting
consider and approve the un-audited financial
BSE Filing ↗Board Meeting
Consider and approve the Audited Standalone Financial Result…
BSE Filing ↗Board Meeting
consider and approve the Un-audited financial results of the…
BSE Filing ↗Board Meeting
Consider and approve the Un-Audited Financial Results
BSE Filing ↗Board Meeting
Consider and approve the Un-Audited Financial Results of the…
BSE Filing ↗Board Meeting
Consider and approve Audited Standalone Financial Results fo…
BSE Filing ↗Board Meeting
Consider and approve Un-Audited Financial Results for the qu…
BSE Filing ↗Board Meeting
Consideration and approval of un-audited standalone financia…
BSE Filing ↗